• AA Rated to Didrex®

 Benzphetamine HCl Tablets 50 mg, CIII

Strength Size NDC
50 mg
50 mg
50 mg
30 count
100 count
500 count
0574-0116-30
0574-0116-01
0574-0116-05

Indicated for the treatment of exogenous obesity.  Contraindicated in patients with symptomatic cardiovascular disease or moderate to severe hypertension.  When tolerance to the anorectic effect develops, the recommended dose should not be exceeded in an attempt to increase the effect; rather, the drug should be discontinued.

For wholesaler stocking numbers contact Paddock Customer Relations.

Read the Material Safety Data Sheet


To read and print the data sheets, you will need to have Adobe Acrobat Reader installed on your computer. You can download a free copy by clicking on the following image.

*Didrex® is a registered trademark of Pfizer, Inc.

 

PADDOCK NEWS

Now Available
Belladonna & Opium Suppository CII

Paddock Receives HDMA DIANA Award

Paddock Laboratories Pharmacy Education Center Now Open

Paddock Appoints
New President and CEO

Paddock Donates
$2 Million: U of M
Pharmacy Program

Buy Glutose Online

Secundum Artem
Now available in PDF form.

Company Profile:
Video now available

NEW PRODUCTS

Bromocriptine Mesylate Tablets, USP

AB Rated to Parlodel®

Neomycin & Polymyxin B Sulfates & Hydrocortisone Otic Suspension, USP

AT Rated to Cortisporin®

Neomycin & Polymyxin B Sulfates & Gramicidin Ophthalmic Solution, USP
AT Rated Generic Alternative

Neomycin & Polymyxin B Sulfates & Hydrocortisone Otic Solution, USP
AT Rated Generic Alternative

Testosterone Cypionate Injection, USP 200 mg/mL CIII
AO Rated to Depo®-Testosterone

Ciclopirox Gel, 0.77%
First Generic Now Available

Testosterone Enanthate Injection USP 200 mg
/mL CIII
AO Rated to Delatestryl®

Benzphetamine HCl Tablets 50 mg, CIII
AA Rated to Didrex®

 

 

 

©2007 All Rights Reserved. Sales Policy.
Paddock Laboratories, Inc., 3940 Quebec Avenue No., Mpls., MN 55427

Hit Counter